Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act

 

Section 1003 Demonstration Project to Increase Substance Use Provider Capacity authorized a new demonstration to help states increase Medicaid substance use disorder provider capacity through education, training, and technical assistance. Through this demonstration, select states were awarded funding to develop and carry out approved activities that enable the state to assess its behavioral health treatment needs and increase the capacity and availability to provide substance use disorder treatment or recovery services for Medicaid beneficiaries. The demonstration includes planning grants and post-planning projects. Under section 1003(aa)(2)(A) (I-IV)), the HHS Secretary awarded planning grants totaling $48.4 million 15 states (based on geographic diversity, with a preference to states with a prevalence of opioid use disorders comparable to or higher than the national average). An additional $1.4 million in supplemental funding was subsequently awarded to the planning grantees. From among the planning grantees, 5 states were selected to receive enhanced federal reimbursement, during a 36-month period, for substance use disorder treatment or recovery services furnished by providers participating under the State plan (or a waiver of such plan).

Active 93.664 Centers For Medicare and Medicaid Services, Department of Health and Human Services B - Project Grants Not applicable. Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, or the SUPPORT for Patients and Communities Act, Section Section 1003, Public Law 115-271 The statutory authority limits eligibility to states including the District of Columbia. Eligible applicants are State Medicaid Agencies (SMAs). Planning grants aimed to increase the capacity of Medicaid providers to provide SUD treatment or recovery services to: Medicaid eligible individuals; low income individuals/families; individuals with disabilities; consumers; individuals with behavioral health disorders including mental health and substance use disorders. Not applicable. Preapplication coordination is required. Applicants were encouraged to submit a non-binding Notice of Intent to Apply. Notices of Intent to Apply were not required and their submission or failure to submit a notice had no bearing on the scoring of proposals received. Receipt of such notices enabled CMS to better plan for the application review process. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Notice of Funding Opportunities (NOFO) for this listing was posted on Grants.gov. Applicants submitted their applications electronically through http://www.grants.gov. Applicants were encouraged to submit a non-binding Letter of Intent to Apply. Letters of Intent to Apply were not required and a state's submission or failure to submit a letter had no bearing on the scoring of proposals received. Applications were awarded based on the outcomes of the Federal review panel. An independent review of all applications was conducted by a panel of experts. The review panel assessed each application to determine the merits of the proposal Final approval of the SUPPORT ACT planning grant awards was made by CMS after consideration of the comments and recommendations of the review panelists, program office recommendations, and the availability of funds. CMS reserved the right to approve or deny any or all proposals for funding. Letter of Intent to Apply Due Date: July 18, 2019 Electronic Application Due Date: August 9, 2019 Contact the regional office for application deadlines. Successful planning grant applicants received a Notice of Award (NoA) prior to September 30, 2019. Unsuccessful applicants were notified by letter, sent through the U.S. Postal Service to the applicant organization as listed on its SF- 424 prior to September 30, 2019. Successful post-planning phase applicants received a Notice of Award (NoA) on September 17, 2021. Appeals are governed by Title 45--Public Welfare SUBTITLE A--DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 16--PROCEDURES OF THE DEPARTMENTAL GRANT APPEALS BOARD. Planning grants agreements were funded on an 18-month basis, with support subsequent years contingent upon acceptable evidence of satisfactory progress, continuing program relevance, and availability of funds. Pursuant to section 1135(b)(5) of the Social Security Act (Act), the end date of the 18-month period for the planning phase of the SUPPORT Act section 1003 Substance Use Disorder Provider Capacity Demonstration was modified to expand 6 months to September 30, 2021. The start of the 36-month post-planning demonstration phase is modified by 6 months to October 1, 2021. For purposes of the Planning Grants, there is appropriated, out of any funds in the Treasury not otherwise appropriated, $50,000,000, to remain available until expended. Applications were screened by Federal staff to determine eligibility for further review using the criteria detailed in the "Eligibility Information" section of this solicitation. Applications were objectively reviewed by a panel of CMS and SAMHSA experts. , The review panel utilized the objective criteria described in the "Application Review Criteria Information" section of this solicitation to establish an overall numeric score for each application. The results of the objective review of applications were used to advise the approving CMS official. Additionally, CMS staff made final recommendations to the approving official after ranking applications using the scores and comments from the review panel and weighing other factors based on geographic diversity, with a preference to states with a prevalence of opioid use disorders comparable to or higher than the national average. Section 1003 (aa)(3) (B)(i-iii) required CMS to select states for planning grants using the following criteria: -Select States with an approved Medicaid State plan (or waiver of the State plan) -Select States in a manner that ensures geographic diversity -Give preference to States with a prevalence of substance use disorders (in particular opioid use disorders) that is comparable to or higher than the national average prevalence, as measured by aggregate per capita drug overdoses, or any other measure that CMS deems appropriate. Performance Reports: Performance monitoring is not required. Not applicable. Recipients are required to maintain grant accounting records 3 years after the date the grant is officially closed. If any litigation, claim, negotiation, audit or other action involving the award has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Planning grants were awarded for an 18 month period; states were required to expend the funds within 18 months of award. Pursuant to section 1135(b)(5) of the Social Security Act (Act), the end date of the 18-month period for the planning phase of the SUPPORT Act section 1003 Substance Use Disorder Provider Capacity Demonstration was modified to expand by 6 months to September 30, 2021. Method of awarding/releasing assistance: Lump. Melanie M. Brown PhD, MPH Centers for Medicare & Medicaid Services 7500 Security Boulevard Mail Stop: S2-13-20 Baltimore, MD 21244-1850 melanie.brown@cms.hhs.gov Melanie M. Brown Ph.D., MPH
7500 Security Boulevard
Baltiimore, MD 21244 USA
melanie.brown@cms.hhs.gov
Phone: 410-786-1095 https://www.medicaid.gov/medicaid/benefits/bhs/support-act-provider-capacity-demos/index.html 75-0516-0-1-551 (Project Grants) FY 22$0.00; FY 23 est $0.00; FY 24 est $0.00; FY 21$1,392,329.00; FY 20$0.00; FY 19$50,000,000.00; FY 18$0.00; - N/A $833,701 - $5,160,581 Not applicable. Not applicable.